Medicines

Innovation Focused
on Complex Diseases

Our Medicines

Alkermes’ technologies and discoveries have contributed to the development of medicines that have helped shape the treatment landscape in a range of disease areas. Our portfolio of proprietary commercial products focuses on alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder.

Proprietary U.S. Medicines

Our mission to make innovative medicines that may help address unmet patient needs underlies our work. Proudly manufactured at our facility in Wilmington, Ohio, our portfolio of proprietary commercial products focuses on chronic, highly prevalent conditions that represent some of the most challenging health issues of our time.

Our proprietary U.S. medicines

Third-Party Medicines

Our proprietary technologies are incorporated into third-party medicines that are commercialized by global pharmaceutical companies for people living with a range of serious diseases.

Learn more about third-party medicines that utilize our proprietary technologies.

U.S. medicines EU medicines

Commitment to patients runs very deep at Alkermes. It starts when we discover new ideas in our labs, continues as we conduct clinical trials, make our medicines, educate stakeholders about unmet needs and support those who take our medicines.